Article info
Clinical science
Pazopanib eye drops: a randomised trial in neovascular age-related macular degeneration
- Correspondence to Dr Ronald Danis, Department of Ophthalmology and Visual Sciences, University of Wisconsin-Madison, School of Medicine and Public Health, 8010 Excelsior Drive, Madison, WI 53717, USA; rpdanis{at}wisc.edu
Citation
Pazopanib eye drops: a randomised trial in neovascular age-related macular degeneration
Publication history
- Received January 13, 2013
- Revised August 27, 2013
- Accepted September 6, 2013
- First published November 13, 2013.
Online issue publication
March 22, 2016
Article Versions
- Previous version (22 March 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions